LIVTENCITY

takeda canada inc🇨🇦 Health Canada

Approval Id: b09bbf762c580d98
Drug Approval Canada Name: LIVTENCITY
Product Name: LIVTENCITY
Status: Marketed
Status Date: 2022-10-25
Original Market Date: 2022-10-25
Din: 02530740
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:18.92
Atc Original: J05AX10 MARIBAVIR
Atc Name: j 05 ax 10
Aig Number: 0164061001
Company Name: takeda canada inc
Company Address: 3800, 22 Adelaide Street West, Toronto, Ontario, Canada, M5H 4E3

MARIBAVIR

200 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

b09bbf762c580d98

Type

Standard